Neonc Technologies (NASDAQ:NTHI) Trading Up 1.7% – Still a Buy?

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI)’s share price was up 1.7% during mid-day trading on Friday . The company traded as high as $10.18 and last traded at $10.00. Approximately 71,158 shares were traded during trading, an increase of 4% from the average daily volume of 68,476 shares. The stock had previously closed at $9.83.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Neonc Technologies in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Neonc Technologies Price Performance

The stock’s 50-day moving average is $8.85 and its 200-day moving average is $7.96.

Neonc Technologies (NASDAQ:NTHI) last released its quarterly earnings results on Friday, November 14th. The company reported ($0.45) EPS for the quarter.

Insiders Place Their Bets

In other news, President Amir F. Heshmatpour purchased 6,000 shares of the firm’s stock in a transaction on Monday, November 24th. The stock was purchased at an average cost of $6.51 per share, with a total value of $39,060.00. Following the purchase, the president owned 2,992,000 shares in the company, valued at $19,477,920. This trade represents a 0.20% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders purchased 31,100 shares of company stock valued at $192,099 in the last three months.

Institutional Trading of Neonc Technologies

Several institutional investors have recently modified their holdings of the company. LVW Advisors LLC acquired a new position in Neonc Technologies during the second quarter worth about $108,000. Westmount Partners LLC boosted its position in shares of Neonc Technologies by 333.7% during the 2nd quarter. Westmount Partners LLC now owns 73,246 shares of the company’s stock valued at $261,000 after purchasing an additional 56,358 shares in the last quarter. HCR Wealth Advisors acquired a new position in shares of Neonc Technologies in the 2nd quarter worth approximately $54,000. SLT Holdings LLC bought a new stake in shares of Neonc Technologies in the 3rd quarter worth approximately $100,000. Finally, Global Retirement Partners LLC bought a new stake in shares of Neonc Technologies in the 3rd quarter worth approximately $434,000.

Neonc Technologies Company Profile

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.